Bifonazole

The in vitro nephrotoxic potential of 3-bromoaniline was studied.3-Bromoaniline was used in the synthesis of amino substituted quinazoline.

The in vitro nephrotoxic potential of 3-bromoaniline was studied.3-Bromoaniline was used in the synthesis of amino substituted quinazoline.

The in vitro nephrotoxic potential of 3-bromoaniline was studied.3-Bromoaniline was used in the synthesis of amino substituted quinazoline.

The in vitro nephrotoxic potential of 3-bromoaniline was studied.3-Bromoaniline was used in the synthesis of amino substituted quinazoline.

Anti-BMS1 BMS1 ribosome biogenesis factor, 100ul UN 1687 6.1

Anti-RBFOX1 RNA binding fox-1 homolog 1, 100ul UN 1687 6.1 P

Anti-RBFOX1 RNA binding fox-1 homolog 1, 25ul UN 1687 6.1 PG

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Biochem/physiol Actions Bifonazole is an imidazole-based anti-fungal agent with broad spectrum activity against many fungi, molds, yeast and some Gram-positive bacteria. Bifonazole inhibits ergosterol biosynthetic protein 28 and Cytochrome P450 2B4.

Biochem/physiol Actions Bifonazole is an imidazole-based anti-fungal agent with broad spectrum activity against many fungi, molds, yeast and some Gram-positive bacteria. Bifonazole inhibits ergosterol biosynthetic protein 28 and Cytochrome P450 2B4.

General description Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Bifonazole

Bifonazole is an antifungal agent and a prostatic aromatase activity inhibitor with IC50 of 1.6 μM.An imidazole antifungal agent and calmodulin antagonist.